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Summary
Introduction: Murine or endemic typhus, caused by Rickettsia typhi, has been
reported in all continents. In the 1970s, no cases of murine typhus were diagnosed
in Tunisia.
Methods: The clinico-epidemiological characteristics of seven cases of murine typhus
diagnosed at our hospitals since 1993 are reported. Diagnosis was confirmed by
indirect fluorescence assay detecting specific R. typhi antibodies.
Results: Murine typhus occurred in all ages from 18—80 years during the hot season in
rural areas. Clinical features were: sudden onset of fever and absence of eschar in all
cases, with maculo-papular rash (five cases), prostration (four cases), meningism
(three cases) and pneumonia (four cases). Frequent laboratory findings were mod-
erate thrombopenia (four cases) and elevated transaminases (four cases). Before the
results of serology, clinical diagnoses were Mediterranean Spotted Fever (four cases),
Q fever (one case), pneumonia (one case), and lymphocytic meningitis (one case).
Serology confirmed all diagnoses with cross-reactivity with Rickettsia conorii.
Conclusion: Murine typhus exists in Tunisia and its prevalence is underestimated.
Further, more specific studies are needed to evaluate the true prevalence.
# 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.* Corresponding author. Present address: Service de Me´decine
Interne et Maladies Infectieuses, CHU F. Hached, 4000 Sousse,
Tunisie. Tel.: +216 73 2111 83; fax: +216 73 2111 83.
E-mail address: amel.letaief@famso.rnu.tn (A.O. Letaı¨ef).
1201-9712/$30.00 # 2005 International Society for Infectious Diseas
doi:10.1016/j.ijid.2004.09.011Introduction
Murine typhus, caused by Rickettsia typhi, is an
endemic zoonosis. Its main vector is the rat flea
Xenopsylla cheopis, which maintains the micro-
organism in rodents. Flea bites and contaminationes. Published by Elsevier Ltd. All rights reserved.
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r.of excoriated skin or the respiratory tract with
inhalation of infected flea feces are the major
sources of human infection.1 Often unrecognized,
murine typhus occurs with high prevalence in the
tropics and has been reported in travellers returning
from coastal tropical and subtropical regions.2—4 In
Africa, little recent reliable information is available
on the prevalence of murine typhus infection. In
Tunisia, a north African country where Mediterra-
nean Spotted Fever (MSF) was first described by
Conor in 1910, rickettsial diseases were largely
described at the beginning of the century.5 Previous
serosurveys indicating the absence of typhus in
Tunisia in the 1970s used inappropriate methods.6
From 1984 to 1992, using a sensitive and specific test
for the diagnosis of rickettsial infections, typhus was
diagnosed in our hospitals7 and relatively high ser-
oprevalence was detected among febrile patients
and blood donors in the region (central Tunisia).8,9
In this study the epidemiological and clinical
characteristics of murine typhus are reported with
the aim of warning physicians of the persistence or
re-emergence of the disease in Tunisia.fi
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Seven patients with a diagnosis of murine typhus
identified between 1993 and 1998 were hospitalized
in the infectious diseases unit of the University
Hospital in central Tunisia. Clinical and epidemio-
logical data were collected from the patients’
charts. Diagnosis was confirmed by a four-fold rise
in antibody titer, or by a single high titer 128 to
typhus group antigen by indirect fluorescent assay
(IFA). All sera cross-reacted to Rickettsia conorii
antigen at lower titer.
Five of the seven cases were diagnosed in 1993
when a previous study (determining the prevalence
of some infections among febrile patients) per-
mitted retrospective diagnosis of murine typhus.
Two other cases were thought to be MSF and com-
plete serology of murine typhus confirmed the diag-
nosis.Ta
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Murine typhus occurred in all ages from 18—80 years
during the hot season from May to October in six
cases and in January in one case. All patients were
from rural or suburban areas; neither flea bites nor
exposure to rats were mentioned.
Sudden onset of fever and headache were
reported in all cases. A rash, noted in four patients
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Table 2 Results of indirect fluorescent assay testing
for antibodies against Rickettsia typhi, Rickettsia con-
orii.
Case R. conorii R. typhi
S1
(IgG/M)
S2
(IgG/M)
S1
(IgG/M)
S2
(IgG/M)
1 0/0 64/32 128/64 1024/256
2 64/0 128/0 64/32 512/64
3 128/16 256/32 128/256 2048/512
4 32/0 ND 1024/128 ND
5 32/0 ND 256/512 ND
6 0/0 40/20 160/20 1280/160
7 40/20 80/40 160/40 1280/320
S1, S2: early serum and convalescent serum; ND: not done.(57%), began around the fifth day of the onset and
was maculopapular and non-confluent. It was dis-
tributed over the trunk and limbs, sparing the face,
palms and soles. There were four cases of pneumo-
nia, with interstitial infiltrates on chest X-ray film in
three cases and alveolar infiltrates in one case.
Meningitis was suspected in three cases and cere-
brospinal fluid showed lymphocytic meningitis in
one case. Clinical and biological features are sum-
marised in Table 1.
Routine laboratory tests showed a normal white
blood cell count in five cases and thrombocytopenia
in four cases. The erythrocyte sedimentation rate
was higher than 40 mm/h in all cases. Liver enzyme
levels were elevated in five cases. Hyponatremia was
present in four cases and hypokalemia in three cases.
In two cases, murine typhus was diagnosed by a
single titer of 512 or higher by IFA. The other five
cases were diagnosed by a four-fold increase of the
initial titer. In all cases, the titers reached against R.
conorii were always lower than those reached
against R. typhi (Table 2).
All patients received antibiotics: four received
doxycycline, two received ciprofloxacin or ofloxacin
and one received cefotaxime. Complications ofmur-
ine typhus were infrequent and included neuropsy-
chiatric abnormalities, meningitis and renal failure.
All cases were cured.Discussion
Rickettsia typhi is found world-wide, but the num-
ber of reported cases does not reflect the current
prevalence. The mild and non-specific features of
infection suggest that its incidence is probably lar-
gely underestimated in tropical countries. However,
the disease is prevalent in Texas, USA, in the Med-
iterranean area (recently reported in Greece, Spain,Portugal, Croatia, Cyprus, and Israel), and in Asia
(Thailand, Vietnam, Japan, Indonesia, China) and in
Africa.3,10,11 Tissot-Dupont noted that the preva-
lence of antibodies reactivewithR. typhi varied from
1—20% in seven African countries and it was higher in
coastal areas where rats are prevalent.12 In Tunisia,
MSFoccursmore frequently during thehot seasonand
is well documented by isolation of R. conorii from
eschar in two patients (in Unite´ des Rickettsies,
Professor D. Raoult; unpublished data), whereas
typhus infection is thought to have disappeared in
the 1970s. Previous studies, however, have suggested
persistence of the infection,7—9 which is underesti-
mated in Tunisia due to the lack of specificity of
symptoms and of physician awareness of murine
typhus. In fact, when systematic serology was per-
formed for acute fever in 1993, five cases of murine
typhus were diagnosed during only one year.
Murine typhus is re-emerging in Tunisia, both
amongst the indigenous population and travellers,
and physicians need to be aware that some of the
classical epidemiological and clinical features may
differ here. Epidemiological features noted in
patients in this study were the association with a
rural area and occurrence during the hot season. So
in that respect it is similar to MSF. However, one
important difference from MSF was the lack of
patient contact with infected fleas, along with
the fact that there was no direct contact with rats.
Such contact was, however, noted in 54% of patients
in a prospective study in Greece.10 The variability in
the clinical presentation of the patients in this study
was reflected in difficulties with the diagnosis. This
was evidenced by two patients who presented with
an initial diagnosis of pneumonia and one with viral
meningitis. The clinical diagnosis of murine typhus is
particularly difficult when the patient is seen early
on in the course of the disease with only isolated
fever and non-specific clinical abnormalities, or the
absence of a rash.
This last presentation (3/7 cases in this study) has
been reported in 20—80% of cases, according to the
stage of illness at consultation.3,11 In a recent
review in the United States, 22 different diagnoses
were proposed for 80 patients with murine typhus.13
When eruptive fever is observed, the main differ-
ential diagnosis in the region is MSF without identi-
fied eschar. So, in the absence of criteria for clinical
diagnosis, it is believed that murine typhus should
be considered routinely in unspecified acute febrile
illness and eruptive fever during the hot season,
especially when associated with thrombocytopenia
and elevated aminotransferases.
The definitive diagnosis of murine typhus, like
other rickettsial infections, requires laboratory con-
firmation based on serologic testing by IFA, the
334 A.O. Letaı¨ef et al.reference method. Latex test, dot blot enzyme-
linked immunosorbent assay and immunoperoxidase
assay have also been described.14 However, detected
antibodies are cross-reactive within the spotted
fever or typhus group and particularly between Rick-
ettsia typhi and Rickettsia prowazekii.15 Rickettsia
felis, recently isolated from patients with murine
typhus-like illness and from cat fleas in many Eur-
opean and American countries, should also be con-
sidered.16—18 Cross-adsorption studies and Western
blotting are useful serological tools for confirma-
tion.15 In this study, cross-adsorption was only per-
formed in five cases. However, differentiation
between murine and epidemic typhus could be made
based on epidemiological and clinical criteria. As for
R. felis, prospective studies should determine its
implication in spotted fever group rickettsial infec-
tion in the central Tunisian region.
In conclusion, it is recommend that physicians
should be alert for murine typhus in Tunisia, where
more specific studies are needed to evaluate the
true prevalence and the epidemiological features of
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